- Your cart is empty
Flowflex antigen test
Self-test
The Flowflex antigen test is a qualitative membrane-based immunoassay for the detection of IgG and IgM antibodies against SARS-COV-2 in human serum, plasma or whole blood.
The test convinces by its easy application and is handy as well as mobile applicable. NO additional instruments are required.
The test convinces by its easy application and is handy as well as mobile applicable. NO additional instruments are required.
The Flowflex antigen test has two key advantages:
The swab only needs to be inserted into the front area of the nasal cavity and does not require a throat swab. After 15 minutes, the result becomes visible - similar to a pregnancy test.
Like other rapid tests, the self-test is particularly suitable for detecting a high viral load. This in turn means that people who are highly infectious can be quickly detected.
The swab only needs to be inserted into the front area of the nasal cavity and does not require a throat swab. After 15 minutes, the result becomes visible - similar to a pregnancy test.
Like other rapid tests, the self-test is particularly suitable for detecting a high viral load. This in turn means that people who are highly infectious can be quickly detected.
BfArM listing:
This test is included in the list of antigen tests for direct pathogen detection of the coronavirus SARS-CoV-2 which are the subject of the claim according to § 1 sentence 1 pursuant to the "Third Ordinance Amending the Ordinance on the Claim to Certain Tests for the Detection of the Presence of an Infection with the Coronavirus SARS-CoV-2 (Coronavirus Test Ordinance - TestV)". Furthermore, the test has been evaluated by the Paul Ehrlich Institute.
BfArM approval
This test is included in the list of antigen tests for direct pathogen detection of the coronavirus SARS-CoV-2 which are the subject of the claim according to § 1 sentence 1 pursuant to the "Third Ordinance Amending the Ordinance on the Claim to Certain Tests for the Detection of the Presence of an Infection with the Coronavirus SARS-CoV-2 (Coronavirus Test Ordinance - TestV)". Furthermore, the test has been evaluated by the Paul Ehrlich Institute.
BfArM approval
- Zu Risiken und Nebenwirkungen lesen Sie bitte die Packungsbeilage und fragen Sie Ihren Arzt oder Apotheker.